It remains unclear whether any modified SRT for relapsed PCa in patients without lymph node metastasis is superior to standard SRT as analyzed here, except for the addition of hormonal treatment for pre-SRT PSA values >0.7 ng/mL. This evidence concerns the gene KLK3 and posterior cortical atrophy.